| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0068-0599-01 | 0068-0599 | HUMAN PRESCRIPTION DRUG | Rifadin IV NOVAPLUS | rifampin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 20170201 | 20251031 | NDA | NDA050627 | Sanofi-Aventis U.S. LLC | RIFAMPIN | 600 mg/10mL | 1 VIAL, GLASS in 1 CARTON (0068-0599-01) / 10 mL in 1 VIAL, GLASS |
| 0068-0597-01 | 0068-0597 | HUMAN PRESCRIPTION DRUG | Rifadin IV | rifampin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | INTRAVENOUS | 19890525 | 20260930 | NDA | NDA050627 | Sanofi-Aventis U.S. LLC | RIFAMPIN | 600 mg/10mL | 1 VIAL, GLASS in 1 CARTON (0068-0597-01) / 10 mL in 1 VIAL, GLASS |